
Keywords: AE; adverse event; CI; confidence interval; GMC; geometric mean concentration; GMFR; geometric mean fold rise; GMT; geometric mean titer; IgG; immunoglobulin G; IPD; invasive pneumococcal disease; MOPA; multiplexed OPA; OPA; opsonophagocytic killing activ